Genetic diversity and recombination at the C-terminal fragment of the merozoite surface protein-1 of Plasmodium vivax (PvMSP-1) in Sri Lanka

Infection, Genetics and Evolution

Volumn 11, Issue 1, 2011, Pages 145-156

  Dias, Sajani ^a   Longacre, Shirley ^b   Escalante, Ananias A ^c   Udagama Randeniya, Preethi V ^a  

^a UNIVERSITY OF COLOMBO   (Sri Lanka)

^b INSTITUT PASTEUR   (France)

^c ARIZONA STATE UNIVERSITY   (United States)

Author keywords

Genetic diversity; Malaria; Merozoite surface protein 142; Plasmodium vivax; Sri Lanka

Indexed keywords

MEROZOITE SURFACE PROTEIN 1;

AMINO ACID SUBSTITUTION; ARTICLE; CARBOXY TERMINAL SEQUENCE; CONTROLLED STUDY; GENE EXPRESSION; GENE IDENTIFICATION; GENE LINKAGE DISEQUILIBRIUM; GENE LOCUS; GENETIC CONSERVATION; GENETIC DATABASE; GENETIC POLYMORPHISM; GENETIC RECOMBINATION; GENETIC VARIABILITY; HAPLOTYPE; MOLECULAR CLONING; NONHUMAN; NUCLEOTIDE SEQUENCE; PHYLOGENY; PLASMODIUM VIVAX; PLASMODIUM VIVAX MALARIA; PRIORITY JOURNAL; SRI LANKA; UNINDEXED SEQUENCE;

ANIMALS; GENETIC VARIATION; MEROZOITE SURFACE PROTEIN 1; PLASMODIUM VIVAX; RECOMBINATION, GENETIC; SRI LANKA;

PLASMODIUM FALCIPARUM; PLASMODIUM VIVAX;

EID: 78650235349     PISSN: 15671348     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.meegid.2010.09.007     Document Type: Article

References (42)

1. Amaratunga, C., 2004. The investigation in to merozoite surface protein-1 vaccination in a natural simian host-parasite system. Ph.D. dissertation. University of Colombo, Sri Lanka.
2. Anderson T.J.C., Haubold B., Williams J.T., Estrada-Franco J.G., Richardson L., Mollinedo R., Bocharie M., Mokili J., Mharakurwa S., French N., Whitworth J., Velez I.D., Brockman A.H., Nosten F., Ferreira M.U., Day K. Microsatellite markers reveal a spectrum of population structures in the malaria parasite Plasmodium falciparum. Mol. Biol. Evol. 2000, 17:1467-1482.
3. Annual Report of the Anti-malaria Campaign, 2007. Ministry of Healthcare and Nutrition, Sri Lanka.
4. Briët, O.J.T., Gunawardena, D.M., van der Hoek, W., Amerasinghe, F.P., 2003. Sri Lanka Malaria Maps. Malaria Journal. 2(22), http://www.malariajournal.com/content/2/1/22.
5. Bruce M.C., Galinski M.R., Barnwell J.W., Snounou G., Day K.P. Polymorphism at the merozoite surface protein-3α locus of Plasmodium vivax: global and local diversity. Am. J. Trop. Med. Hyg. 1999, 61:518-525.
6. Chen Q., Schlichtherle M., Wahlgren M. Molecular aspects of severe malaria. Clin. Microbiol. Rev. 2000, 13(3):439-450.
7. Cole-Tobian J., King C.L. Diversity and natural selection in Plasmodium vivax Duffy binding protein gene. Mol. Biochem. Parasitol. 2003, 127:121-132.
8. Conway D.J., Cavanagh D.R., Tanabe K., Roper C., Mikes Z.S., Sakihama N., Bojang K.A., Oduola A.M.J., Kremsner P.G., Arnot D.E., Greenwood B.M., McBride J.S. A principal target of human immunity to malaria identified by molecular population genetic and immunological analyses. Nat. Med. 2000, 6:689-692.
9. Cowman A.F., Crabb B.S. Invasion of red blood cells from malaria parasites. Cell 2006, 124:755-766.
10. EL-Manzalawy Y., Dobbs D., Honavar V. Predicting flexible length linear B-cell epitopes. 7th International Conference on Computational Systems Bioinformatics 2008, 121-132.
11. Escalante A., Lal A.A., Ayala F.J. Genetic polymorphism and natural selection in the malaria parasite Plasmodium falciparum. Genetics 1998, 149:189-202.
12. Escalante A.A., Cornejo O.E., Rojas A., Udhayakumar V., Lal A.A. Assessing the effect of natural selection in malaria parasites. Trends Parasitol. 2004, 20:388-395.
13. Ferreira M.U., da Silva-Nunes M., Wunderlich G. Antigenic diversity and immune evasion by malaria parasites. Clin. Diagn. Lab. Immunol. 2004, 11:987-995.
14. Fonseka J., Mendis K.N. A metropolitan hospital in a non-endemic area provides a sampling pool for epidemiological studies on vivax malaria in Sri Lanka. T. Roy. Soc. Trop. Med. H 1987, 81:360-364.
15. Galinski M.R., Barnwell J.W. Plasmodium vivax: who cares?. Malar J. 2008, 7(1). 10.1186/1475-2875-7-S1-S9.
16. Gardiner D.L., McCarthy J.S., Trenholme K.R. Malaria in the post-genomics era: light at the end of the tunnel or just another train?. Postgrad. Med. J. 2005, 81:505-509.
17. Gibson H.L., Tucker J.E., Kaslow D.C., Krettli A.U., Collins W.E., Kiefer M.C., Bathurst I.C., Barr P.J. Structure and expression of the gene for Pv200, a major blood stage surface antigen of Plasmodium vivax. Mol. Biochem. Parasitol. 1992, 50:325-334.
18. Gunasekera A.M., Wickramarachchi T., Neafsy D.E., Ganguli I., Perera L., Premaratne P.H., Hartl D., Handunnetti S.M., Udagama-Randeniya P.V., Wirth D.F. Genetic diversity and selection at the Plasmodium vivax Apical Membrane Antigen-1 (Pvama-1) locus in a Sri Lankan population. Mol. Biol. Evol. 2007, 24(4):939-947.
19. Holder A. Malaria vaccines: where next?. Plos Pathogens 2009, 5(10):e1000638. 10.1371/journal.ppat.1000638.
20. Konradsen F., Amerasinghe F.P., Van der Hoek W., Amerasinghe P.H. Malaria in Sri Lanka: Current Knowledge on Transmission and Control 2000, IWMI, Colombo, Sri Lanka.
21. Longacre S. The Plasmodium cynomolgi merozoite surface protein-1 C-terminal sequence and its homologies with other Plasmodium species. Mol. Biochem. Parasitol. 1995, 74(1):105-111.
22. Manamperi, A., 2002. Preliminary preparation towards malaria vaccine trials in Sri Lanka; studies on genetic polymorphism and immune responses against the C-terminal merozoite surface protein-1. Ph.D. Thesis, University of Colombo, Sri Lanka.
23. Mendis C., Gamage-nendis A.C., de Zoyza A.P.K., Abhayawardena T.A., Carter R., Herath P.R.J., Mendis K.N. Characteristics of malaria transmission in Kataragama, Sri Lanka: a focus for immuno-epidemiological studies. Am. J. Trop. Med. Hyg. 1990, 42(4):298-308.
24. Pacheco M.A., Poe A.C., Collins W.E., Lal A.A., Tanabe K., Kariuki S.K., Udhayakumar V., Escalante A.A. A comparative study of the genetic diversity of the 42kDa fragment of the merozoite surface protein-1 in Plasmodium falciparum and P. vivax. Infect. Genet. Evol. 2007, 7:180-187.
25. Pasay M.C., Cheng Q., Rzepczyk C., Saul A. Dimorphism of the C-terminus of the Plasmodium vivax merozoite surface protein-1. Mol. Biochem. Parasitol. 1995, 70:217-219.
26. Perera K.L.R.L., Handunnetti S.M., Holm I., Longacre S., Mendis K. Baculovirus merozoite surface protein 1 C-terminal recombinant antigens are highly protective in a natural primate model for human Plasmodium vivax malaria. Infect. Immun. 1998, 66(4):1500-1506.
27. Price R.N., Tjitra E., Guerra C.A., Yeung S., White N.J., Anstey N.M. Vivax malaria: neglected and not benign. Am. J. Trop. Med. Hyg. 2007, 77:79-88.
28. Putaporntip C., Jongwutiwes S., Seethamchai S., Kanbara H., Tanabe K. Intragenic recombination in the 3′ portion of the merozoite surface protein-1 gene of Plasmodium vivax. Mol. Biochem. Parasitol. 2000, 109:111-119.
29. Putaporntip C., Jongwutiwes S., Sakihama N., Ferreira M.U., Kho W.G., Kaneko A., Kanbara H., Hattori T., Tanabe K. Mosaic organization and heterogeneity in frequency of allelic recombination of the Plasmodium vivax merozoite surface protein-1 locus. Proc. Natl. Acad. Sci. U.S.A. 2002, 99:16348-16353.
30. Putaporntip C., Jongwutiwes S., Iwasaki T., Kanbara H., Hughes A.L. Ancient common ancestry of the merozoite surface protein-1 of Plasmodium vivax as inferred from its homologue in Plasmodium knowlesi. Mol. Biochem. Parasitol. 2006, 146:105-108.
31. Rozas J., Sánchez-delbarrio J.C., Messeguer X., Rozas R. DnaSP 4.50, DNA polymorphism analyses by the coalescent and other methods. Bioinformatics 2003, 19:2496-2497.
32. Sawai, H., Otani, H., Arisue, N., Palacpac, N., Martins, L., Pathirana, S., Handunnetti, S., Kawai, S., Kishino, H., Horii, T., Tanabe, K., 2010. Lineage-specific positive selection at the merozoite surface protein-1 (msp-1) locus of Plasmodium vivax and related simian malaria parasites. BMC Evol. Biol. 10(52), http://www.biomedcentral.com/1471-2148/10/52.
33. Singh H., Raghava G.P.S. ProPred: prediction of HLA-DR binding sites. Bioinformatics 2001, 17(12):1236-1237.
34. Soares I.S., Barnwell J.W., Ferreira M.U., Gomes Da Cunha M., Laurino J.P., Laurino J.P., Castilho B.A., Rodrigues M.M. A Plasmodium vivax vaccine candidate displays limited allele polymorphism, which does not restrict recognition by antibodies. Mol. Med. 1999, 5:459-470.
35. Southwood S., Sidney J., Kondo A., del Guercio M.F., Appella E., Hoffman S., Kubo R.T., Chesnut R.W., Grey H.M., Sette A. Several common HLA-DR types share largely overlapping peptide binding repertoires. J. Immunol. 1998, 160:3363-3373.
36. Tamura K., Dudley J., Nei M., Kumar S. MEGA4: molecular evolutionary genetics analysis (MEGA) software version 4.1. Mol. Biol. Evol. 2007, 24:1596-1599.
37. Tanabe K., Mackay M., Goman M., Scaife J.G. Allelic dimorphism in a surface gene of the malaria parasite Plasmodium falciparum. J. Mol. Biol. 1987, 195:273-287.
38. Tanabe K., Escalante A., Sakihama N., Honda M., Arisue N., Horii T., Culleton R., Hayakawa T., Hashimoto T., Longacre S., Pathirana S., Handunnetti S., Kishino H. Recent independent evolution of MSP-1 polymorphism in Plasmodium vivax and related simian malaria parasites. Mol. Biochem. Parasitol. 2007, 156:74-79.
39. 42) among Indian isolates. Acta Trop. 2008, 108:58-63.
40. Wickramarachchi T., Illeperuma R.J., Perera L., Bandara S., Holm I., Longacre S., Handunnetti S.M., Udagama-Randeniya P.V. Comparison of naturally acquired antibody responses against the C-terminal processing products of Plasmodium vivax Merozoite Surface Protein-1 under low transmission and unstable malaria conditions in Sri Lanka. Int. J. Parasitol. 2007, 37:199-208.
41. Wickramarachchi T., Premaratne P.H., Dias S., Handunnetti S.M., Udagama-Randeniya P.V. Genetic complexity of Plasmodium vivax infections in Sri Lanka, as reflected at the merozoite-surface-protein-3α locus. Ann. Trop. Med. Parasitol. 2010, 104(2):95-108.
42. World Malaria Report, 2008. World Health Organization, Geneva, Switzerland.